Biotech Company MouSensor Closes Seed Round with $3.3 Million

Biotech Company MouSensor Closes Seed Round with $3.3 Million


Biotechnology company MouSensor, Inc., has raised $3.3 million in its seed round, which was co-led by imec.xpand and Alexandria Venture Investments and in participation with New York Ventures and Elma Hawkins, Ph.D. MouSensor develops a platform that digitizes smell, providing objective means to measure odors . Its core technology was developed by co-founders Paul Feinstein, Ph.D., and Charlotte d'Hulst, Ph.D., at the Feinstein Lab for Neurogenetics at Hunter College of the City University of New York.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога